Performers / Professionals From Around The Globe

Tracks & Key Topics

cancertherapy esc 2020

About Conference

The EuroSciCon will be organizing the Cancer Therapy ESC 2020 Online/Webinar event which is going to be held in the midst of November 16-17, 2020 focusing on current and future Research in Cancer science. The theme of this year’s meeting is “Decimate the outbreak of COVID-19 through Cancer Therapy”, which will provide an international platform for discussion and sharing the advancements in the Cancer Science research for present and future expansions in various fields of Cancer. World-leading Oncologist, Health practitioners, educators and researchers will present their novel research and provide an insight to the current research and future expansions in Cancer Therapy.

What’s new?

Cancer Therapy Esc 2020 includes international attendee workshops, Lectures, Symposia and Exhibitions. We welcome the world leading experts in the field of Oncology and Cancer Science, who will be sharing their research and will be discussing about advancements and current research in Cancer. So, come and join leading experts and allied professionals on November 16-17, 2020

Join the top Cancer Conferences and get to explore more in Cancer Therapy 2020, this November. Major topics the Cancer Conference will be focusing this year includes,

Cancer Immunology

Chemotherapy

Oncology

Breast Cancer

Cancer Treatments

Cancer

Cancer Science

Carcinogenesis

Stem Cell & Cancer

Sessions and Tracks

Cancer Research

Cancer analysis helps to spot causes, and develop methods for hindrance, diagnosis, treatment and cure. Cancer analysis might concerned Scientists from Chemistry, organic chemistry, medicine Engineering, Physiology or Molecular background.

Types of Research

Fundings in Cancer Research

Participation of Patients in Cancer Research

Future of Cancer Research

Cancer Pathophysiology

Malignant growth happens because of uncontrolled development of cells. In Dysplasia a cell varies from the ordinary parent cell fit as a fiddle. Metaplasia is the beginning phase of Dysplasia. In Hyperplasia the cell check increments.

Dysplasia

Metaplasia

Hyperplasia

Genetic Changes

Solid Tumor Parts

Cancer Epidemiology

Malignancy the study of disease transmission is the investigation of the appropriation and determinants of the probability of malignancy improvement. Malignant growth the study of disease transmission can be utilized to distinguish occasions that expansion or diminishing malignant growth occurrence in explicit populaces.

Cancer & Types

There are many types of Cancer out of which some common types of Cancer include, Breast Cancer, Prostate Cancer, Lung Cancer, Skin Cancer,Ovarian Cancer, Lymphoma, Pancreatic Cancer, Bone Cancer. The major cause of Lung Cancer includes higher smoking rates, which directly affect the lungs.

Skin Cancer

Breast Cancer

Ovarian Cancer

Lung Cancer

Prostate Cancer

Oral Cancer

Bladder Cancer

Thyroid Cancer

Cancer & Oncology Case Reports

Case Reports are detailed report of the patient who has been diagnosed with the disease. This report includes signs & symptoms, diagnosis, treatment methods of that particular patient. Some of the case reports may contain a Review of Literature of previous reported cases of some patients.

Case Reports on Cancer

Oncology Case Reports

Types of Case Reports

Clinical Case Reports

Medical Case Reports

Cancer Biomarkers

Biomarkers are those molecules which serve as indicator for the processes that may occur in a body for a disease for which the patient has been diagnosed. Cancer Biomarkers are those biological molecules that may help to detect if a person is having Cancer. Some major examples of Biomarkers that has been used for diagnosis of cancer are, ER/PR (Used for Breast Cancer), Eml4/ALK (used for Lung Cancer). Additionally, biomarkers are generally used in clinical practice to identify patients with favorable prognoses who can safely avoid overtreatment.

Use of Biomarkers in Cancer Research

Cancer Biomarker Discovery

Biomarker Development

Validation of Biomarkers

Availability of Cancer Biomarkers

Biomarkers and Breast Cancer

Infectious Diseases and Oncology

Infectious diseases are disorders caused by organisms like bacterium, viruses, fungi or parasites. Several organisms sleep in and on our bodies. They are unremarkably harmless or may be useful, however below sure conditions, some organisms might cause illness. Some infectious diseases are passed from person to person. Some are transmitted by bites from insects or animals. And others are non-inheritable by ingesting contaminated food or water or being exposed to organisms within the surroundings. Signs and symptoms vary looking on the organism inflicting the infection; however usually embody fever and fatigue. Delicate infections might reply to rest and residential remedies, whereas some serious infections might need hospitalization. Several infectious diseases, like contagious disease and varicella, is prevented by vaccines. Frequent and thorough hand-washing additionally helps defend you from most infectious diseases.

Surgical and Clinical Oncology

Clinical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumour, tumour site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

Stages of Cancer

There are 4 Stages of Cancer, which include Stage 0 (There is no cancer, but some abnormal cells that may give rise to cancerous cells) Stage 1 (Cancer is located in small area) Stage 2 & 3 (Cancer has spread to larger area including tissues and lymph nodes), Stage 4 (Cancer has spread to many parts of the body)

Different Stages of Cancer

Reoccurrence of Cancer

Local & Malignant Cancer

Various treatment measures at different stages of cancer

Cancer Diagnosis

Cancer Screening at the earliest stage of Cancer helps to cure the cancer at the very earliest stage of Cancer. Cancer Diagnosis include tests such as, Physical examination, which may be visible (abnormalities such as lumps, change in skin color or enlarged organ). It also includes, Laboratory tests, Imaging or Biopsy.

Tests used for Cancer Diagnosis

Cancer Diagnosis and cure of cancer

Cancer stage and Diagnosis of Cancer

Future expansions in Cancer Diagnosis

Anti-Cancerous Diet

Eating health foods can prevent cancer. Cancer could be cured to some extent if a patient follows good and health diet, which generally includes fruits and raw green leafy vegetables. Some of which includes, Apple, Papaya, Banana, Carrots, Tomatoes, etc which have high antioxidant properties, and thus a potential to cure cancer.

Anticancer Vegetables

Anticancer Fruits

Food as a source to prevent Cancer

Cancer Nanotechnology

Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterials (such as nanoparticles for tumour imaging or drug delivery) and nanotechnology approaches (such as nanoparticle-based theranostics) to the diagnosis and treatment of cancer.

Cancer Immunology and Immunotherapy

Cancer immunology helps us to understand the response of the immune system while the cancer progression has begun to occur. Cancer immunotherapy utilizes the immune system for treating the cancer. Cancer immunotherapy proves to be more effecting, lost lasting and more specific as compared to other methods.

Cancer Immunotherapy

Immunodiagnostic

Immunoediting

Future expansions in Cancer Immunology

Stem Cell Therapy & Cancer Research

Stem cell transplants include process that restores the blood-forming stem cells in people who have had destroyed their cells by the very high doses of chemotherapy or radiation therapy that were used to treat certain cancers. Different types of Stem cell Transplants include Autologous, Allogeneic and Syngeneic

Use of Stem Cell in Cancer Treatment

Stem Cell Transplant Procedures

Stem Cell Transplant Side Effects

Types of Stem Cell Transplant

Challenges in Stem Cell Transplant

Cancer Nursing

Oncology Nurse is a Specialist who take cares of Cancer patients. Oncology nursing care could be defined as the special care and completing the needs of patients during the time of their disease, while may involve some screening methods and preventive measures that should be taken care of.

Cancer Nursing Care

Oncology Nursing Education

Roles of an Oncology Nurse

Cancer Awareness

According to the National Cancer Institute, the second leading cause of death is Cancer in the US. Information and education about Cancer are the key to cancer prevention, early detection of Cancer and to have the best treatment options.

Food Habits and Cancer

Public Education

Awareness Programs

Cancer Research Awareness

Cancer Survivorship

A cancer patient who has had cancer is know as a Cancer Survivor. Cancer Survivorship has 2 meanings, having no signs of cancer after the treatment has been completed and secondly living with cancer.

Phases of Survivorship

Cancer patients survival rates

Survivorship Care Plans

Care before & after Treatment

Learn More

European Cancer Institutions

USA Cancer Institutions

Asian Cancer Institutions

African Cancer Institutions

Cancer Journals

Top European Journals

Top USA Journals

Top Asian Journals

Top UK Journals

Cancer Hospitals in Europe

Cancer Hospitals in USA

Cancer Hospitals in Asia

Cancer Hospitals in UK

Cancer Associations Europe

Cancer Associations USA

Cancer Associations Asia

Cancer Associations UK

Past Conference Report

We are thankful to all our Attendees, Media Partners & Associations for making 15th World Congress on Advance Cancer Research Conference the successful!

1st Edition of World Congress on Oncology and Immuno Oncology 2018 & 2019 hosted by the EuroSciCon Ltd. was held during October 14-15. 2019 at HOLIDAY INN PARIS - PORTE DE CLICHY, 2 rue du 8 mai 1945-92 110 Clichy., Paris the France with theme “Expanding Horizons in Cancer Research : New approaches for Cancer treatment & a win over Cancer" . We are also thankful for the support and guidance of Organizing Committee Members and Editorial Board Members and wonderful presentations from our participants which actually made this event a grand success.

EuroSciCon Ltd expresses its gratitude to the conference Moderator, namely Dr Mohamed Mostafa Rizk, University of Alexandria, Egypt for who took the responsibility to coordinate during the sessions for the smooth functioning of this event.

The conference was initiated with the Honourable presence of the Keynote forum. The speaker's list includes:

Alaa AlQurashi, King Fahad Medical City - KFMC, Saudi Arabia
Omkara M Veeranki, The University of Texas MD Anderson Cancer Center, USA
Feraru Aurelia, Craiova University, Romania
Mona Sayed Abdellateif, National Cancer Institute-Cairo, Egypt
Georg Voelcker, Goethe University Frankfurt, Germany
Dodo Tavdidishvili , Akaki Tsereteli State University, Georgia
Dr. Weisi Yan, University of South Alabama, USA
Dr. Donglu Shi, University of Cincinnati, USA
Dr. Igor Smit, Ijsselland Ziekenhuis, Netherlands
Dr. Kenji Ohe, Fukuoka University, Japan
Dr. Dwayne N. Jackson, University of Western Ontario, Canada
Dr. Mohamed Mostafa Rizk, University of Alexandria, Egypt
Dr. Jiangwen Zhang, University of Hong Kong, Hong Kong
Dr. María del Rosario Davalos Gamboa, University of San Simon, Bolivia
Dr. Jose Antonio Matute Briceno, Sonora Cancer Research Center-Cics USA, Mexico
Dr. Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
Dr. Mohammed Y Almaghrabi, Jing Abdullah Medical City, Kingdom of Saudi Arabia
Dr. Jan Jacques Michiels, Goodheart Institute and Foundation in Nature Medicine & Health, Netherlands
Dr. Kamlesh Guleria, Guru Nanak Dev University, India

Various sessions on which discussions were held included the following major scientific tracks:

Cancer
Types of Cancer
Cancer Survivorship
Cancer & Oncology Case Report
Cancer Treatment
Immuno-Oncology Studies
Combining Cancer Immunotherapies
Immune Checkpoint Inhibitors
Radiology And Imaging In Cancer
Cancer Prognosis & Diagnosis
Cancer Micro And Immuno Environment
Stem Cell Therapy
Biomarker And Drug Targeting
Cancer Pharmacology
Cancer Biomarkers
Cancer Genomics And Metabolomics
Immuno-Oncology Studies
Cancer & HIV
Oncology
Clinical Oncology
Tumor Immunology
Types Of Cancer
Cancer Research & Cancer Vaccines
Antibody Therapy Of Cancer
Neuro Immunology
Tumour Immunotherapy Research
Radiation Oncology

Euroscicon Ltd is again glad to announce the next Conference, 16^th World Congress on Advance Cancer Research which will be held during June 24-25, 2020 in Rome,Italy

We welcome you once again to join us at our esteemed event & make it a huge success.

Market Analysis

In 2019, the global cancer therapy market was valued at USD 136,254.35 million, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. Factors that are driving the market growth include

Increased Patient Assistance Programs (PAPs)
Increased government initiatives for cancer awareness
Rising prevalence of cancer worldwide
Strong R&D initiatives from major research in Cancer

Target Therapy Segment is Expected to show the Fastest Growth in the Forecast Period

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy basically includes hormone therapies, angiogenesis

inhibitors, immunotherapies, signal transduction inhibitors, gene expression modulators, apoptosis inducers, and toxin delivery molecules. Targeted therapy is getting great importance due to its high specificity toward cancerous cells, while eliminating the toxicity to off-target cells.

The Blood cancer segment is believed to account for the largest market size over the forecast period. This is majorly attributed to the higher and continuously increasing prevalence of breast cancer across the world. Over 2,66,120 new cases of invasive blood cancer are expected to be diagnosed in men, women, small children in the US, as per estimated by the Blood Cancer Organizations in 2019 along with 63,960 new cases of non-invasive (in situ) blood cancer.

North America currently dominates the market for cancer therapy. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy. The United States holds majority of the market in the North American region, due to the rising prevalence of cancer in the country. In 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer, as reported by the National Cancer Institute (NCI). This figure indicates that the prevalence of cancer is rapidly increasing in the United States.